Workflow
Geomega provides update on Montviel hydrometallurgical process developments
Globenewswire· 2025-06-17 11:30
Core Viewpoint - Geomega Resources Inc. has made significant advancements in the hydrometallurgical process for the Montviel rare earth deposit, aiming to enhance project economics and reduce environmental impact compared to previous studies [2][3][4]. Process Improvements - The hydrometallurgical testwork has led to the removal of the flotation circuit, which previously accounted for 15% rare earth element (REE) loss to tailings, thus reducing operating costs and capital expenditures [5]. - The process flow sheet has been simplified, cutting the number of steps compared to earlier patented work [5]. - The project now aims to valorize other metals present in the ore, which helps mitigate financial risks associated with rare earth price fluctuations [5]. Economic and Environmental Benefits - The project is expected to recover approximately 40% of the overall ore into various offtake streams, enhancing economic viability [5]. - Recovery of high-purity iron and other critical minerals, including rare earth elements, scandium, and niobium, is projected to be around 95% for REO and Sc, and 85% for Nb [5]. - The recovery of iron phosphate and manganese/magnesium salts is anticipated to create additional revenue streams for the agricultural and battery markets [5]. Technical Assessment - An internal techno-economic assessment was completed using Aspen Plus software, with further external work required before a Preliminary Economic Assessment (PEA) can be published [3]. - The positive conclusions from the internal study will guide the next steps in advancing the Montviel deposit [3][6]. Support and Collaboration - The project has received financial support from the Quebec government, highlighting the province's commitment to developing the critical and strategic mineral industry [4]. - Geomega is focused on working with major partners to extract value from mining feeds and industrial residues, emphasizing a consistent approach to reducing environmental impact [9].
Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy
Globenewswire· 2025-06-17 11:30
Expanded platform improves access, scales operations, and advances Incannex’s position in next-generation mental health treatmentNEW YORK and MELBOURNE, Australia, June 17, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact indications, announces entering into a 50:50 joint venture with Mind Medicine Australia (“MMA”) to operate a psychedelic-assisted therapies service ...
ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart™ Test in Detecting Esophageal Cancer
Globenewswire· 2025-06-17 11:30
Core Insights - ProPhase Labs Inc. has successfully completed a validation study for its BE-Smart molecular diagnostic test, achieving a technical success rate of over 95% in detecting biomarkers related to esophageal diseases [2][3] - The BE-Smart test is designed to work with both brush and forceps biopsies, positioning it uniquely in the market and targeting a potential market size of approximately $10 billion [4] - The increasing adoption of brush biopsies in clinical practice is driven by their improved diagnostic yield and safety profile, addressing limitations of traditional forceps biopsies [5][6] Company Overview - ProPhase Labs Inc. is a next-generation biotech and genomics company focused on innovative healthcare solutions, including diagnostic tests for early detection of esophageal cancer [8] - The company aims to revolutionize healthcare through bold innovation and actionable insights, with a commitment to executional excellence and smart diversification [9] Industry Context - Esophageal adenocarcinoma (EAC) has seen a dramatic increase in incidence, with a 750% rise since the 1970s and a 5-year mortality rate exceeding 79%, highlighting the urgent need for effective diagnostic tools [3] - The shift towards brush biopsies is gaining traction in both the U.S. and internationally, with expanded payer coverage now reaching over 73 million lives, indicating a growing recognition of their benefits [6][7]
Solar stocks plummet as Senate version of Trump's tax bill cuts renewable energy incentives
CNBC· 2025-06-17 11:24
The Senate version of the bill includes a provision that would fully phase out both solar and wind power tax incentives by 2028. It does, however, keep incentives for nuclear, hydropower and geothermal energy for longer. The renewable energy incentives were key pillars of former President Joe Biden's Inflation Reduction Act. "The House-passed version generally represented a worst-case scenario for the majority of the IRA's tax incentives; while the Senate proposal still represents a material negative for re ...
Blackstone Secured Lending: Portfolio Resilience And Excess Capital Make This BDC Attractive
Seeking Alpha· 2025-06-17 11:22
Financial analyst by day and a seasoned investor by passion, I've been involved in the world of investing for over 15 years and honed my skills in analyzing lucrative opportunities within the market.I specialize in uncovering high quality dividend stocks and other assets that offer potential for long term-growth that pack a serious punch for bill-paying potential. I use myself as an example that with a solid base of classic dividend growth stocks, sprinkling in some Business Development Companies, REITs, an ...
USANA CEO Elected to Board of Direct Selling Association
Prnewswire· 2025-06-17 11:17
SALT LAKE CITY, June 17, 2025 /PRNewswire/ -- USANA President and CEO Jim Brown has been elected to the Board of Directors of the Direct Selling Association (DSA), a national trade organization for direct sales companies. Mr. Brown was elected by members of the Association and will serve a three-year term. USANA CEO Jim Brown Elected to Board of Direct Selling Association "I am deeply honored to serve this outstanding organization, which plays a vital role in fostering innovation and upholding integrit ...
United Airlines: Why UAL Stock Is An Undervalued Play On Oil Relief
Forbes· 2025-06-17 11:15
TOPSHOT - The first direct scheduled flight from US' Newark airport to Nuuk's airport is landing in ... More Nuuk, Greenland, on June 14, 2025. United Airlines flight from the US has been in transit for four hours to the new international airport in Nuuk. (Photo by Mads Claus Rasmussen / Ritzau Scanpix / AFP) / Denmark OUT (Photo by MADS CLAUS RASMUSSEN/Ritzau Scanpix/AFP via Getty Images)Ritzau Scanpix/AFP via Getty Images Airline stocks surged on June 16, with United Airlines (NASDAQ: UAL) leading the cha ...
Draganfly's Commander 3XL Integrated with TB2 Aerospace's DROPS System Achieves 100% Success Rate During U.S. Army's SMEX25 Operational Trials
Globenewswire· 2025-06-17 11:15
In alignment with the Presidential Executive Order “Unleashing American Drone Dominance” Golden, CO, June 17, 2025 (GLOBE NEWSWIRE) -- TB2 Aerospace LLC, in collaboration with Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, (NASDAQ: DPRO), is proud to announce the successful deployment and performance of the Drone Recharging Operational Payload System (DROPS) during the U.S. Army’s Sustainment Modernization Experiment 2025 (SMEX ...
Can Darden Restaurants Deliver In Its Next Earnings?
Forbes· 2025-06-17 11:10
DRI 1D, 5D, and 21D Post Earnings Return AUSTIN, TEXAS - DECEMBER 19: The exterior of a LongHorn Steakhouse restaurant is seen on December ... More 19, 2024 in Austin, Texas. (Photo by Brandon Bell/Getty Images) Getty Images Darden Restaurants (NYSE: DRI), a specialist in the full-service dining restaurant chain, is set to announce its fiscal fourth-quarter earnings (ending in May) on Friday, June 20, 2025, with analysts estimating earnings of $2.94 per share on $3.25 billion in revenue. This would indicate ...
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
Globenewswire· 2025-06-17 11:05
- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications - - CLS-AX Combines the Flexibility of Anti-VEGF Therapies with the Long-Lasting Benefits of a Tyrosine Kinase Inhibitor - ALPHARETTA, Ga., June 17, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that the use of its SCS de ...